510(k) Report

510(k) · Cleared

Cleared

Accusign Tca, Biosign Tca, Staus DS Tca

K980249510(k) TraditionalCleared Mar 13, 199849-day reviewClass II21 CFR 862.3910

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Princeton BioMeditech Corp. · LFG Radioimmunoassay, Tricyclic Antidepressant Drugs

Cleared on Mar 13, 1998 after a 49-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 93 later devices descend from it.

Decided
Mar 13, 1998
Review
49 days
Class
Class II
Product code
LFG
Recalls
None
Predicates
0

93 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared2004: 3 descendants cleared2003: 2 descendants cleared2011: 2 descendants cleared2006: 3 descendants cleared2013: 3 descendants cleared2005: 1 descendant cleared2009: 1 descendant cleared2014: 4 descendants cleared2016: 9 descendants cleared2015: 9 descendants cleared2012: 1 descendant cleared2018: 9 descendants cleared2020: 4 descendants cleared2023: 7 descendants cleared2019: 6 descendants cleared2017: 2 descendants cleared2025: 7 descendants cleared2021: 3 descendants cleared2024: 9 descendants cleared2022: 3 descendants cleared2026: 4 descendants cleared1995200020052010201520202025
  1. This deviceK980249 Accusign Tca, Biosign Tca, Staus DS TcaPrinceton BioMeditech Corp. · 1998
  2. Descendant · cites it directly · 92 of its ownK021526 Acon Tca One Step Tricyclic Antidepressant Test Strip and DeviceACON Laboratories, Inc. · 2002
  3. Descendant · 2 generations on · 86 of its ownK023946 Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step…ACON Laboratories, Inc. · 2003
  4. Descendant · 3 generations on · 83 of its ownK031759 Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon…ACON Laboratories, Inc. · 2003 · Recalled
  5. Descendant · 4 generations on · 80 of its ownK061718 Innovacon Spectrum II Test CardInnovacon, Inc. · 2006 · Recalled
  6. Descendant · 5 generations on · 55 of its ownK122809 Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech · 2013

Showing 5 of 93 descendants. See all descendants

Descendants cleared per year

2002: 12003: 22004: 32005: 12006: 32009: 12011: 22012: 12013: 32014: 42015: 92016: 92017: 22018: 92019: 62020: 42021: 32022: 32023: 72024: 92025: 72026: 4
2002high 9 (2015) · low 0 (2007)2026

Most influential descendants

Showing 5 of 93 · See all
  • K021526Acon Tca One Step Tricyclic Antidepressant Test Strip and DeviceACON Laboratories, Inc. · 2002 · cites it directly92descendants
  • K023946Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step Multi-Drug…ACON Laboratories, Inc. · 2003 · 2 generations on86descendants
  • K031759Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum Multi-Drug…ACON Laboratories, Inc. · 2003 · 3 generations on83descendants
  • K061718Innovacon Spectrum II Test CardInnovacon, Inc. · 2006 · 4 generations on80descendants
  • K122809Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech · 2013 · 5 generations on55descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K980249Accusign Tca, Biosign Tca, Staus DS TcaPrinceton BioMeditech Corp.1998—
+1K021526Acon Tca One Step Tricyclic Antidepressant Test Strip and DeviceACON Laboratories, Inc.2002—
+2K023946Acon One Step Multi-Drug Multi-Line Screen Test Card, Acon One Step Multi-Drug…ACON Laboratories, Inc.2003—
+3K031759Acon Spectrum Multi-Drug Multi-Line Drug Screen Test Card and Acon Spectrum…ACON Laboratories, Inc.20031
+4K061718Innovacon Spectrum II Test CardInnovacon, Inc.20066
+5K122809Advin Multi-Drug Screen Test Cassette, Dip Card and CupAdvin Biotech2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200320
200430
200510
200630
200910
201120
201210
201330
201440
201590
201690
201720
201890
201960
202040
202130
202230
202370
202490
202570
202640
FIG. 1 — Lineage of K980249, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (93)

See all 93

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K021526Acon Tca One Step Tricyclic Antidepressant Test Strip and DeviceACON Laboratories, Inc.200292

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K021526 (ACON Laboratories, Inc., 2002) has gone furthest, with 92 descendants of its own.

How does its category compare?

All LFG devices

LFG Radioimmunoassay, Tricyclic Antidepressant Drugs: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFG

1in 2015

2007: 12011: 12014: 12015: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFG

Too few LFG 510(k)s in any year since 2007 to give a median.

Recalls per year · LFG

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFG

1in 2024

2012: 12017: 12020: 12024: 1
2007high 1 (2012) · low 0 (2007)2025

MAUDE reports naming product code LFG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—00
20100—00
20111—00
20120—01
20130—00
20141—00
20151—00
20160—00
20170—01
20180—00
20190—00
20200—01
20210—00
20220—00
20230—00
20240—01
20250—00
20260—1—

What is it indicated for?

Immunoassay for the qualitative detection of TCA in human urine to assist in screening of drug of abuse samples and/or diagnosis of clinical symptoms associated with the use of drugs

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K980249: Accusign Tca, Biosign Tca, Staus DS Tca.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K980249

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026